retatrutide side effects clinical trial results 2025 trials 💉 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗦𝗵𝗼𝘂𝗹𝗱 𝗞𝗻𝗼𝘄 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲: a new triple-agonist weight loss drug that is STILL IN Retatrutide Shows 28% Weight Loss

However, I would suggest that GLP-1s might be a unique case study, potentially not fully representative of the broader pharmaceutical market

Early trial data show even greater weight loss than tirzepatide, approaching 24-25% at 48 weeks

10.15420/ecr.2018.33.1 Eur Cardiol Rev

Conclusion MOTS-c is a breakthrough peptide for targeting visceral fat, improving mitochondrial health, reversing insulin resistance, and enhancing metabolic resilience

If cost is the primary barrier, Trulicity may be $50 to $150/month cheaper depending on your plan

Tirzepatide (Mounjaro): A newer medication that also aids in blood sugar control and significant weight loss